CIK 0000899923
- Accelerated filer
MYRIAD GENETICS INC
Sign in to watch- Ticker
- MYGN
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 870494517
- Phone
- +1 801-584-3600
- Business address
- 322 NORTH 2200 WEST, SALT LAKE CITY, UT, 84116
- Former names
- MYRIAD GENETICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $34,252
- in 1 filing
Net −$34,252. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-09-30 | King Gary A. Exec. VP International Ops | Returned to the company | −4,050 | $36.18 | $147K | 125,439 |
| 2017-09-30 | King Gary A. Exec. VP International Ops | Returned to the company | −3,522 | $36.18 | $127K | 121,917 |
| 2017-09-30 | Capone Mark Christopher President & C.E.O. | Returned to the company | −19,367 | $36.18 | $701K | 341,413 |
| 2017-09-30 | Capone Mark Christopher President & C.E.O. | Returned to the company | −9,238 | $36.18 | $334K | 332,175 |
| 2017-09-30 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −5,869 | $36.18 | $212K | 144,268 |
| 2017-09-30 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −5,459 | $36.18 | $198K | 138,809 |
| 2017-09-30 | MARSH RICHARD M E.V.P., General Counsel | Returned to the company | −5,869 | $36.18 | $212K | 143,176 |
| 2017-09-30 | MARSH RICHARD M E.V.P., General Counsel | Returned to the company | −5,291 | $36.18 | $191K | 137,885 |
| 2017-09-17 | Ford Alexander President, MGL | Returned to the company | −1,937 | $33.05 | $64K | 88,780 |
| 2017-09-17 | McDade Ralph L President Myriad RBM, Inc. | Returned to the company | −2,188 | $33.05 | $72K | 111,877 |
| 2017-09-17 | King Gary A. Exec. VP International Ops | Returned to the company | −5,400 | $33.05 | $178K | 129,489 |
| 2017-09-17 | Capone Mark Christopher President & C.E.O. | Returned to the company | −11,671 | $33.05 | $386K | 360,780 |
| 2017-09-17 | LANCHBURY JERRY S Chief Scientific Officer | Returned to the company | −6,897 | $33.05 | $228K | 150,137 |
| 2017-09-17 | MARSH RICHARD M E.V.P., General Counsel | Returned to the company | −6,684 | $33.05 | $221K | 149,045 |
| 2017-09-13 | Ford Alexander President, MGL | Grant or award | +60,000 | 90,717 | ||
| 2017-09-13 | Tobin Bernard President Crescendo BioScience | Grant or award | +40,000 | 157,862 | ||
| 2017-09-13 | Riggsbee Richard Bryan Chief Financial Officer | Grant or award | +60,000 | 126,152 | ||
| 2017-09-13 | McDade Ralph L President Myriad RBM, Inc. | Grant or award | +30,000 | 114,065 | ||
| 2017-09-13 | Verratti Mark President Assurex Health Inc. | Grant or award | +40,000 | 50,000 | ||
| 2017-09-13 | King Gary A. Exec. VP International Ops | Grant or award | +30,000 | 134,889 |
Page 46 of 60 · 1,194 trades